International stocks trading in New York were mixed on Tuesday.
The BNY Mellon index of American depositary receipts rose 0.43% to
139.64. The European index increased 0.67% to 137.42, the Asian
index improved 0.25% to 143.40, the Latin American index fell 1% to
228.86 and the emerging markets index eased 0.03% to 266.52. Among
the companies with shares that actively traded was SAP SE (SAP,
SAP.XE).
SAP on Tuesday dropped its medium-term profit-margin guidance
and reported its fourth-quarter profit fell 1%, in the latest sign
the German business-software provider's shift from on-premise
software to Internet cloud-based products is holding back growth.
Shares fell 5.3% to $63.56.
The U.S. Supreme Court on Tuesday reversed an appeals court
ruling that invalidated a Teva Pharmaceutical Industries Ltd.
(TEVA, TEVA.TV) patent on the blockbuster multiple-sclerosis drug
Copaxone, giving the drug maker a new opportunity to forestall
generic competition. Shares rose 1.2% to $58.44.
Unilever PLC (UL, ULVR.LN) said weakening demand in emerging
markets, especially China, has showed no sign of letting up this
year even as the consumer-goods group reported a higher profit for
2014. The maker of Dove soap, Axe deodorant and Hellmann's
mayonnaise, has relied heavily on emerging markets to drive growth
in the past decade. Shares fell nearly 1% to $41.37.
Write to Tess Stynes at tess.stynes@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires